Literature DB >> 27229914

Serum-based protein profiles of Alzheimer's disease and mild cognitive impairment in elderly Hispanics.

Alcibiades E Villarreal1,2, Sid E O'Bryant3, Melissa Edwards4, Shantal Grajales1, Gabrielle B Britton1.   

Abstract

AIM: To describe the biomarker profiles in elderly Panamanians diagnosed with Alzheimer's disease (AD), mild cognitive impairment (MCI) or no impairment using serum-based biomarkers.
METHODS: Twenty-four proteins were analyzed using an electrochemiluminescence-based multiplex biomarker assay platform. A biomarker profile was generated using random forest analyses.
RESULTS: Two proteins differed among groups: IL-18 and T-lymphocyte-secreted protein I-309. The AD profile was highly accurate and independent of age, gender, education and Apolipoprotein E ε4 status. AD and MCI profiles had substantial overlap among the top markers, suggesting common functions in AD and MCI but differences in their relative importance.
CONCLUSION: Our results underscore the potential influence of genetic and environmental differences within Hispanic populations on the proteomic profile of AD.

Entities:  

Keywords:  Hispanic; Latin America; aging; blood-based biomarkers; cognition; dementia

Mesh:

Substances:

Year:  2016        PMID: 27229914      PMCID: PMC5066121          DOI: 10.2217/nmt-2015-0009

Source DB:  PubMed          Journal:  Neurodegener Dis Manag        ISSN: 1758-2024


  58 in total

1.  Demographic and health conditions of ageing in Latin America and the Caribbean.

Authors:  Alberto Palloni; Guido Pinto-Aguirre; Martha Pelaez
Journal:  Int J Epidemiol       Date:  2002-08       Impact factor: 7.196

2.  Global prevalence of dementia: a Delphi consensus study.

Authors:  Cleusa P Ferri; Martin Prince; Carol Brayne; Henry Brodaty; Laura Fratiglioni; Mary Ganguli; Kathleen Hall; Kazuo Hasegawa; Hugh Hendrie; Yueqin Huang; Anthony Jorm; Colin Mathers; Paulo R Menezes; Elizabeth Rimmer; Marcia Scazufca
Journal:  Lancet       Date:  2005-12-17       Impact factor: 79.321

3.  Biomarkers of Alzheimer's disease among Mexican Americans.

Authors:  Sid E O'Bryant; Guanghua Xiao; Melissa Edwards; Michael Devous; Veer Bala Gupta; Ralph Martins; Fan Zhang; Robert Barber
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

4.  Does ethnicity moderate dementia's biomarkers?

Authors:  Donald R Royall; Raymond F Palmer
Journal:  Neurobiol Aging       Date:  2013-09-18       Impact factor: 4.673

Review 5.  Apolipoprotein E ε4 prevalence in Alzheimer's disease patients varies across global populations: a systematic literature review and meta-analysis.

Authors:  Sheila Crean; Alex Ward; Catherine J Mercaldi; Jenna M Collins; Michael N Cook; Nicole L Baker; H Michael Arrighi
Journal:  Dement Geriatr Cogn Disord       Date:  2010-12-01       Impact factor: 2.959

Review 6.  The future of blood-based biomarkers for Alzheimer's disease.

Authors:  Kim Henriksen; Sid E O'Bryant; Harald Hampel; John Q Trojanowski; Thomas J Montine; Andreas Jeromin; Kaj Blennow; Anders Lönneborg; Tony Wyss-Coray; Holly Soares; Chantal Bazenet; Magnus Sjögren; William Hu; Simon Lovestone; Morten A Karsdal; Michael W Weiner
Journal:  Alzheimers Dement       Date:  2013-07-11       Impact factor: 21.566

7.  The Global Deterioration Scale for assessment of primary degenerative dementia.

Authors:  B Reisberg; S H Ferris; M J de Leon; T Crook
Journal:  Am J Psychiatry       Date:  1982-09       Impact factor: 18.112

8.  Markers of inflammation and cognitive decline in an African-Caribbean population.

Authors:  Vesna Jordanova; Robert Stewart; Emma Davies; Roy Sherwood; Martin Prince
Journal:  Int J Geriatr Psychiatry       Date:  2007-10       Impact factor: 3.485

9.  Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome dataset.

Authors:  Daniel Johnstone; Elizabeth A Milward; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

Review 10.  Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview.

Authors:  Frederic Brosseron; Marius Krauthausen; Markus Kummer; Michael T Heneka
Journal:  Mol Neurobiol       Date:  2014-02-25       Impact factor: 5.590

View more
  13 in total

Review 1.  Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.

Authors:  Piotr Lewczuk; Peter Riederer; Sid E O'Bryant; Marcel M Verbeek; Bruno Dubois; Pieter Jelle Visser; Kurt A Jellinger; Sebastiaan Engelborghs; Alfredo Ramirez; Lucilla Parnetti; Clifford R Jack; Charlotte E Teunissen; Harald Hampel; Alberto Lleó; Frank Jessen; Lidia Glodzik; Mony J de Leon; Anne M Fagan; José Luis Molinuevo; Willemijn J Jansen; Bengt Winblad; Leslie M Shaw; Ulf Andreasson; Markus Otto; Brit Mollenhauer; Jens Wiltfang; Martin R Turner; Inga Zerr; Ron Handels; Alexander G Thompson; Gunilla Johansson; Natalia Ermann; John Q Trojanowski; Ilker Karaca; Holger Wagner; Patrick Oeckl; Linda van Waalwijk van Doorn; Maria Bjerke; Dimitrios Kapogiannis; H Bea Kuiperij; Lucia Farotti; Yi Li; Brian A Gordon; Stéphane Epelbaum; Stephanie J B Vos; Catharina J M Klijn; William E Van Nostrand; Carolina Minguillon; Matthias Schmitz; Carla Gallo; Andrea Lopez Mato; Florence Thibaut; Simone Lista; Daniel Alcolea; Henrik Zetterberg; Kaj Blennow; Johannes Kornhuber
Journal:  World J Biol Psychiatry       Date:  2017-10-27       Impact factor: 4.132

2.  Improved Discrimination of Disease States Using Proteomics Data with the Updated Aristotle Classifier.

Authors:  David Hua; Heather Desaire
Journal:  J Proteome Res       Date:  2021-04-28       Impact factor: 4.466

3.  The clinical correlation of proinflammatory and anti-inflammatory biomarkers with Alzheimer disease: a meta-analysis.

Authors:  Urati Anuradha; Anoop Kumar; Rakesh Kumar Singh
Journal:  Neurol Sci       Date:  2021-05-25       Impact factor: 3.830

4.  A proteomic signature for dementia with Lewy bodies.

Authors:  Sid E O'Bryant; Tanis J Ferman; Fan Zhang; James Hall; Otto Pedraza; Zbigniew K Wszolek; Tori Como; David Julovich; Sravan Mattevada; Leigh A Johnson; Melissa Edwards; James Hall; Neill R Graff-Radford
Journal:  Alzheimers Dement (Amst)       Date:  2019-03-15

5.  Inflammatory Biomarkers, Depressive Symptoms and Falls Among the elderly in Panama.

Authors:  Gabrielle B Britton; Sid E O'Bryant; Leigh A Johnson; James R Hall; Alcibiades E Villarreal; Diana C Oviedo; Ambar R Pérez-Lao; María B Carreira
Journal:  Curr Aging Sci       Date:  2019

6.  Potential two-step proteomic signature for Parkinson's disease: Pilot analysis in the Harvard Biomarkers Study.

Authors:  Sid E O'Bryant; Melissa Edwards; Fan Zhang; Leigh A Johnson; James Hall; Yuliya Kuras; Clemens R Scherzer
Journal:  Alzheimers Dement (Amst)       Date:  2019-05-02

7.  Vascular biomarkers and ApoE4 expression in mild cognitive impairment and Alzheimer's disease.

Authors:  Diana C Oviedo; Hector Lezcano; Ambar R Perez; Alcibiades E Villarreal; Maria B Carreira; Baltasar Isaza; Lavinia Wesley; Shantal A Grajales; Sara Fernandez; Ana Frank; Gabrielle B Britton
Journal:  AIMS Neurosci       Date:  2018-06-16

8.  Proteomic profiles of incident mild cognitive impairment and Alzheimer's disease among adults with Down syndrome.

Authors:  Sid E O'Bryant; Fan Zhang; Wayne Silverman; Joseph H Lee; Sharon J Krinsky-McHale; Deborah Pang; James Hall; Nicole Schupf
Journal:  Alzheimers Dement (Amst)       Date:  2020-05-21

9.  A blood screening test for Alzheimer's disease.

Authors:  Sid E O'Bryant; Melissa Edwards; Leigh Johnson; James Hall; Alcibiades E Villarreal; Gabrielle B Britton; Mary Quiceno; C Munro Cullum; Neill R Graff-Radford
Journal:  Alzheimers Dement (Amst)       Date:  2016-06-25

Review 10.  IL-1β, IL-6, TNF- α and CRP in Elderly Patients with Depression or Alzheimer's disease: Systematic Review and Meta-Analysis.

Authors:  Ada Ng; Wilson W Tam; Melvyn W Zhang; Cyrus S Ho; Syeda F Husain; Roger S McIntyre; Roger C Ho
Journal:  Sci Rep       Date:  2018-08-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.